| abstract |
The present invention relates to a mixture of stereoisomeric forms of any or all proportions thereof. [Chemical 1] (Wherein the substituents are as described herein) Or a physiologically acceptable salt thereof. The compounds of the present invention have CXCR5 inhibitory activity and are particularly useful for the treatment or prevention of various inflammatory diseases such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's disease associated with modulation of the human CXCR5 receptor It is. |